Navigation Links
Alexza Elects Dr. Hal V. Barron to Its Board of Directors
Date:12/19/2007

PALO ALTO, Calif., Dec. 19 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it has elected Hal V. Barron, MD, FACC to its Board of Directors. Dr. Barron is currently Senior Vice President, Development and Chief Medical Officer at Genentech, where he leads the Development organization, which is responsible for pre-clinical, clinical and post-approval activities.

Dr. Barron joined Genentech in 1996 as a clinical scientist and was promoted in 2002 to Vice President of Medical Affairs. In 2003 he was promoted to Senior Vice President and head of Development, and in 2004 was appointed as Chief Medical Officer. Dr. Barron received his medical degree from Yale University and holds a Bachelor of Science degree in physics from Washington University.

Dr. Barron's current academic positions at the University of California, San Francisco include Associate Adjunct Professor of Epidemiology and Biostatistics, and Associate Clinical Professor of Medicine/Cardiology. He has been issued several patents for his work in thrombosis and angiogenesis, and has published more than 90 papers in peer-reviewed scientific journals.

"We are very pleased to welcome Dr. Barron to our Board of Directors," said Thomas B. King, President and CEO of Alexza Pharmaceuticals, Inc. "During 2008, we plan to have six product candidates in clinical development and to initiate our first Phase 3 program. Dr. Barron's breadth of experience in clinical research, clinical development and portfolio management will be valuable to us in this next stage of Alexza's development."

Alexza Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel, proprietary products for the t
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. The 4th Annual BIO Investor Forum to Webcast Alexzas Corporate Presentation
2. 19th Annual Piper Jaffray Health Care Conference to Webcast Alexzas Corporate Presentation
3. KGI Elects Three New Members to Board of Trustees
4. The Pittsburgh Life Sciences Greenhouse Elects Four New Members to Its Board of Directors
5. Genaera Elects New Board Member and Announces Executive Appointments
6. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
7. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
8. Detroit Department of Health and Wellness Promotion Selects Netsmart Technologies Public Health Software
9. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
10. E-Rad Solutions Selects Compressus Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market
11. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 PAREXEL ... global clinical research organization , announced ... definitive agreement to acquire all of the ... a leading provider of specialized pharmacovigilance services, ... the collection, detection, assessment, monitoring, and prevention ...
(Date:3/25/2015)... of the most attractive in the emerging European region, ... economy and increasing government investment in healthcare, according to ... is set to grow at twice the pace of ... annually reaching an approximate market value of $43-60 billion ... Green Cross provides total healthcare solutions that address the ...
(Date:3/25/2015)... 25, 2015  S&P Capital IQ (MHFI) announced ... Report coverage on Abattis Bioceuticals Corp . ... is a specialty biotechnology company with capabilities through ... marketing proprietary ingredients, bio-similar compounds, patented equipment and ... North America . The company seeks to ...
(Date:3/25/2015)... SPRINGS, Fla. , March 25, 2015 /PRNewswire/ ... strategy and management consulting firm, has launched the ... publication to simplify tracking of ePrescribing regulatory requirements ... "The ePrescribing regulatory landscape continues to change ... to deliver what the industry, and ultimately patients, ...
Breaking Biology Technology:PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 2PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 3PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Point-of-Care Partners Launches the ePrescribing State Law Capsule 2
... March 23, 2011 Tengion, Inc. (Nasdaq: ... the addition of two renal research and clinical experts, ... from the Harvard Stem Cell Institute and ... & Development Advisors. This panel provides counsel to Tengion ...
... nanotubes dipped in a polymer solution equal the energy output ... of Case Western Reserve University engineers has found. The ... power output and maintain the other advantages by matching the ... they,ve proved the simple technique can knock down one of ...
... Spherix Incorporated (Nasdaq: SPEX), ... diabetes, metabolic syndrome and atherosclerosis; and providers of ... biotechnology and pharmaceutical companies, today announced that its ... the BIO-Windhover/Pharmaceutical Strategic Outlook 2011 Conference to be ...
Cached Biology Technology:Tengion Announces Addition of Two Renal Experts to Research & Development Advisors Panel 2Tengion Announces Addition of Two Renal Experts to Research & Development Advisors Panel 3Tengion Announces Addition of Two Renal Experts to Research & Development Advisors Panel 4Tengion Announces Addition of Two Renal Experts to Research & Development Advisors Panel 5Cheap catalyst made easy 2Spherix to Present at the BIO-Windhover/Pharmaceutical Strategic Outlook 2011 Conference 2Spherix to Present at the BIO-Windhover/Pharmaceutical Strategic Outlook 2011 Conference 3
(Date:3/23/2015)... NEW YORK , March 23, 2015   ... digital property management company, today announced that the Company ... platform for both enterprise and consumers at Connect:ID on ... D.C. HOYOS Labs will highlight the IEEE ... 1U TM ; and enterprise access control system. ...
(Date:3/20/2015)... , Mar. 20, 2015 Research and Markets ... addition of the "India Sensors Market Forecast ... The sensor market is projected to ... Consumer electronics, automotive, industrial and healthcare ... in the country. In addition, adoption of MEMS ...
(Date:3/20/2015)... , Mar. 19, 2015 Research and Markets ... "Iris Biometrics - Global Strategic Business Report" report to ... for Iris Biometrics in US$ Thousands. The report provides separate ... Japan , Europe , ... , and Latin America . ...
Breaking Biology News(10 mins):HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
... biomedical and health informatics, sent comments to the federal ... (DHHS/ ONCHIT), which has actively supported and incentivized the ... over the last year, and which solicited comment, through ... support for achieving meaningful use of EHRs in 2013 ...
... A new non-surgical post-mortem technique that has the ... the world has been pioneered by forensic pathologists and ... the University Hospitals of Leicester NHS Trust. The ... Forensic Pathology Unit, at the University of Leicester, has ...
... how farmers could protect themselves by growing a greater ... BioScience , has highlighted economical steps that farmers ... global climate change, including a greater frequency of extreme ... a policy priority for agriculture. The survey, by Brenda ...
Cached Biology News:AMIA on meaningful use: Invest in people and technology 2New non-surgical autopsy technique set to revolutionize post-mortem practice 2
... Concentrated x 10 This pH 9.9 ... prior to immunohistochemical staining procedures. It is ... mounted on glass slides. For particular antigens, ... especially effective. It should be noted that ...
... 9 (x 10) This product is ... heat-induced target retrieval prior to immunohistochemical staining ... formalin-fixed, paraffin-embedded tissue sections mounted on glass ... pH 6, the use of Target Retrieval ...
... Maximizer kit, 110 to 220 V, ... and doubles flow rates and valve ... The kit includes the Maximizer base ... kit, tubing kit, system cable 30, ...
MAb to Yersinia pestis F1 Ag. Yersinia pestis F1 Antigen EB Strain...
Biology Products: